Published in Mol Pharmacol on April 05, 2006
Direct involvement of sigma-1 receptors in the dopamine D1 receptor-mediated effects of cocaine. Proc Natl Acad Sci U S A (2010) 1.35
Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors. Br J Pharmacol (2009) 1.25
Pharmacology of signaling induced by dopamine D(1)-like receptor activation. Pharmacol Ther (2010) 1.02
Pharmacological analysis of the novel, rapid, and potent inactivation of the human 5-Hydroxytryptamine7 receptor by risperidone, 9-OH-Risperidone, and other inactivating antagonists. Mol Pharmacol (2008) 0.99
Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance. Neuropsychopharmacology (2013) 0.96
Dopamine receptor homooligomers and heterooligomers in schizophrenia. CNS Neurosci Ther (2010) 0.89
Characterization of in vivo pharmacokinetic properties of the dopamine D1 receptor agonist DAR-0100A in nonhuman primates using PET with [11C] NNC112 and [11C] raclopride. J Cereb Blood Flow Metab (2010) 0.80
Deletion of the NMDA-NR1 receptor subunit gene in the mouse nucleus accumbens attenuates apomorphine-induced dopamine D1 receptor trafficking and acoustic startle behavior. Synapse (2013) 0.78
Probing the steric space at the floor of the D1 dopamine receptor orthosteric binding domain: 7α-, 7β-, 8α-, and 8β-methyl substituted dihydrexidine analogues. J Med Chem (2011) 0.76
D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci U S A (2006) 2.48
Building a new conceptual framework for receptor heteromers. Nat Chem Biol (2009) 2.41
Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem (2004) 2.32
Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet (2002) 2.16
Compressing genomic sequence fragments using SlimGene. J Comput Biol (2011) 2.10
Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth. Proc Natl Acad Sci U S A (2009) 1.67
Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. Proc Natl Acad Sci U S A (2005) 1.67
Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors. J Biol Chem (2003) 1.57
Localizing value of ictal-interictal SPECT analyzed by SPM (ISAS). Epilepsia (2005) 1.39
Re: Suprascapular nerve studies--surface versus needle pickup electrodes. PM R (2009) 1.39
The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia. J Biol Chem (2010) 1.33
A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of mu and delta opioid receptor hetero-oligomers. J Biol Chem (2005) 1.20
The dopamine d1-d2 receptor heteromer in striatal medium spiny neurons: evidence for a third distinct neuronal pathway in Basal Ganglia. Front Neuroanat (2011) 1.19
Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers. Mol Pharmacol (2009) 1.19
Modification of the terminal residue of apelin-13 antagonizes its hypotensive action. Endocrinology (2004) 1.17
Neuronal Gq/11-coupled dopamine receptors: an uncharted role for dopamine. Trends Pharmacol Sci (2007) 1.16
D1 and D2 dopamine receptors form heterooligomers and cointernalize after selective activation of either receptor. Mol Pharmacol (2005) 1.16
Trafficking of preassembled opioid mu-delta heterooligomer-Gz signaling complexes to the plasma membrane: coregulation by agonists. Biochemistry (2007) 1.16
Oligomerization of opioid receptors: generation of novel signaling units. Curr Opin Pharmacol (2002) 1.14
D2 dopamine receptor homodimerization is mediated by multiple sites of interaction, including an intermolecular interaction involving transmembrane domain 4. Biochemistry (2003) 1.13
Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity. Trends Pharmacol Sci (2006) 1.13
The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study. PLoS One (2009) 1.11
Heteromerization of dopamine D2 receptors with dopamine D1 or D5 receptors generates intracellular calcium signaling by different mechanisms. Curr Opin Pharmacol (2009) 1.11
Insights into the role of dopamine receptor systems in learning and memory. Rev Neurosci (2007) 1.10
Deletion of dopamine D1 and D3 receptors differentially affects spontaneous behaviour and cocaine-induced locomotor activity, reward and CREB phosphorylation. Eur J Neurosci (2005) 1.09
GPCR-OKB: the G Protein Coupled Receptor Oligomer Knowledge Base. Bioinformatics (2010) 1.09
Novel human G-protein-coupled receptors. Biochem Biophys Res Commun (2003) 1.08
Regulation of D1 dopamine receptor trafficking and signaling by caveolin-1. Mol Pharmacol (2007) 1.07
Dopamine D1-D2 receptor heteromer signaling pathway in the brain: emerging physiological relevance. Mol Brain (2011) 1.06
Natural evolution of Perthes disease: a study of 610 children under 12 years of age at disease onset. J Pediatr Orthop (2003) 1.06
Homo- and hetero-oligomerization of G protein-coupled receptors. Life Sci (2003) 1.05
Imaging onset and propagation of ECT-induced seizures. Epilepsia (2007) 1.04
Requirements and ontology for a G protein-coupled receptor oligomerization knowledge base. BMC Bioinformatics (2007) 1.04
The antipsychotic potential of l-stepholidine--a naturally occurring dopamine receptor D1 agonist and D2 antagonist. Psychopharmacology (Berl) (2008) 1.00
Dopamine receptor oligomerization visualized in living cells. J Biol Chem (2005) 1.00
Distinct residues in the carboxyl tail mediate agonist-induced desensitization and internalization of the human dopamine D1 receptor. J Biol Chem (2001) 0.97
Attenuation of sucrose reinforcement in dopamine D1 receptor deficient mice. Eur J Neurosci (2003) 0.97
A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors. Clin Endocrinol (Oxf) (2008) 0.96
Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance. Neuropsychopharmacology (2013) 0.96
The fate of the internalized apelin receptor is determined by different isoforms of apelin mediating differential interaction with beta-arrestin. Biochem Biophys Res Commun (2010) 0.96
How does a femoral varus osteotomy alter the natural evolution of Perthes' disease? J Pediatr Orthop B (2005) 0.95
Minireview: Diversity and complexity of signaling through peptidergic G protein-coupled receptors. Endocrinology (2004) 0.94
Desensitization of the dopamine D1 and D2 receptor hetero-oligomer mediated calcium signal by agonist occupancy of either receptor. Mol Pharmacol (2007) 0.94
Phasic D1 and tonic D2 dopamine receptor signaling double dissociate the motivational effects of acute nicotine and chronic nicotine withdrawal. Proc Natl Acad Sci U S A (2012) 0.94
Dopamine D1-D2 receptor Heteromer-mediated calcium release is desensitized by D1 receptor occupancy with or without signal activation: dual functional regulation by G protein-coupled receptor kinase 2. J Biol Chem (2010) 0.93
Using Genome Query Language to uncover genetic variation. Bioinformatics (2013) 0.93
Optimal timing for containment surgery for Perthes disease. J Pediatr Orthop (2003) 0.93
A uniform projection method for motif discovery in DNA sequences. IEEE/ACM Trans Comput Biol Bioinform (2006) 0.93
Dopamine D1-D2 receptor heteromer in dual phenotype GABA/glutamate-coexpressing striatal medium spiny neurons: regulation of BDNF, GAD67 and VGLUT1/2. PLoS One (2012) 0.92
Separation and reformation of cell surface dopamine receptor oligomers visualized in cells. Eur J Pharmacol (2011) 0.92
Disruption of the mu-delta opioid receptor heteromer. Biochem Biophys Res Commun (2012) 0.91
A usability study of a computerized decision aid to help patients with, early stage papillary thyroid carcinoma in, decision-making on adjuvant radioactive iodine treatment. Patient Educ Couns (2010) 0.91
Dopamine receptor homooligomers and heterooligomers in schizophrenia. CNS Neurosci Ther (2010) 0.89
Two amino acids in each of D1 and D2 dopamine receptor cytoplasmic regions are involved in D1-D2 heteromer formation. Biochem Biophys Res Commun (2011) 0.89
Mu-opioid receptor heterooligomer formation with the dopamine D1 receptor as directly visualized in living cells. Eur J Pharmacol (2007) 0.88
Advancing drug discovery for schizophrenia. Ann N Y Acad Sci (2011) 0.86
Using ligand-induced conformational change to screen for compounds targeting G-protein-coupled receptors. J Biomol Screen (2007) 0.85
Non-amine-based dopamine transporter (reuptake) inhibitors retain properties of amine-based progenitors. Eur J Pharmacol (2003) 0.84
A physiological role for the dopamine D5 receptor as a regulator of BDNF and Akt signalling in rodent prefrontal cortex. Int J Neuropsychopharmacol (2012) 0.84
Prevalence of hypocalcaemia and its associated features in 22q11·2 deletion syndrome. Clin Endocrinol (Oxf) (2014) 0.83
D5 dopamine receptor carboxyl tail involved in D5-D2 heteromer formation. Biochem Biophys Res Commun (2013) 0.81
A cysteinyl leukotriene 2 receptor variant is associated with atopy in the population of Tristan da Cunha. Pharmacogenetics (2003) 0.81
A G protein-coupled receptor for estrogen: the end of the search? Mol Interv (2005) 0.81
Dopamine D₁-D₂ receptor heteromer regulates signaling cascades involved in addiction: potential relevance to adolescent drug susceptibility. Dev Neurosci (2014) 0.80
The role of palmitoylation in directing dopamine D1 receptor internalization through selective endocytic routes. Biochem Biophys Res Commun (2011) 0.80
Discovery of a null mutation in a human trace amine receptor gene. Genomics (2003) 0.80
Synthesis and Biological Evaluation of N-Fluoroalkyl and 2-Fluoroalkoxy Substituted Aporphines: Potential PET Ligands for Dopamine D(2) Receptors. ACS Med Chem Lett (2011) 0.79
Blockade of G protein-coupled receptors and the dopamine transporter by a transmembrane domain peptide: novel strategy for functional inhibition of membrane proteins in vivo. J Pharmacol Exp Ther (2003) 0.78
Continued discovery of ligands for G protein-coupled receptors. Life Sci (2003) 0.78
Striatal development involves a switch in gene expression networks, followed by a myelination event: implications for neuropsychiatric disease. Synapse (2012) 0.78
Restoration of amphetamine-induced locomotor sensitization in dopamine D1 receptor-deficient mice. Psychopharmacology (Berl) (2009) 0.77
Enhanced brain-derived neurotrophic factor signaling in the nucleus accumbens of juvenile rats. Dev Neurosci (2013) 0.76
Family 1 G protein-coupled receptor function in the CNS. Insights from gene knockout mice. Brain Res Brain Res Rev (2003) 0.75
Novel G-protein-coupled receptor genes expressed in the brain: continued discovery of important therapeutic targets. Expert Opin Ther Targets (2002) 0.75
Intermediate colloidal formation and the varying width of periodic precipitation bands in reaction-diffusion systems. J Colloid Interface Sci (2005) 0.75
Postnatal maternal deprivation and pubertal stress have additive effects on dopamine D2 receptor and CaMKII beta expression in the striatum. Int J Dev Neurosci (2013) 0.75
Establishment of a university academic spine center: from concept to reality. J Med Pract Manage (2013) 0.75
Dynamics of anti-M antibody response in a mouse model following intranasal infection with group A Streptococcus M-18. J Med Microbiol (2005) 0.75